Panacea Index Logo

Command Palette

Search for a command to run...

Quality of life among women diagnosed with breast Cancer: A randomized waitlist controlled trial of commercially available mobile app-delivered mindfulness training.

Psycho-oncology
August 1, 2018
Kristen D Rosen et al. (5 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the efficacy of commercially available mobile app-delivered mindfulness training (AMT) on quality of life (QOL) and dispositional mindfulness in women diagnosed with breast cancer, compared to a waitlist control.

Results Summary

Participants using AMT reported significantly higher QOL and dispositional mindfulness compared to the control group, with effects sustained through follow-up. However, fewer AMT participants completed all study assessments, indicating potential feasibility challenges.

Population

Women diagnosed with breast cancer within the past 5 years (n=112).

Effective Dosage

Not specified

Duration

8 weeks of intervention, with 4 weeks of follow-up (12 weeks total).

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
commercially available mobile app-delivered mindfulness training (AMT)
increase
quality of life (QOL)
women diagnosed with breast cancer
t(258.40) = 3.09, P < 0.01, 95% CI [2.71, 11.90]
reported higher
#1
commercially available mobile app-delivered mindfulness training (AMT)
increase
dispositional mindfulness
women diagnosed with breast cancer
t(268.44) = 2.04, P = 0.04, 95% CI [0.01, 0.57]
reported higher
#2
commercially available mobile app-delivered mindfulness training (AMT)
decrease
study completion
women diagnosed with breast cancer
-
Fewer participants assigned to AMT completed all study assessments
#3
Abstract

OBJECTIVE: The primary objective was to evaluate the efficacy of commercially available mobile app-delivered mindfulness training (AMT), compared with waitlist control (WC), on quality of life (QOL) among women diagnosed with breast cancer. The secondary outcome was dispositional mindfulness. Enrollment, app utilization, and study completion are reported as feasibility objectives. METHODS: Women diagnosed with breast cancer ≤5 years (n = 112) were randomized to AMT (n = 57) or WC (n = 55), over 8 weeks, with 4 weeks of follow-up. We conducted linear mixed effects models to examine group by observation interactions on QOL and dispositional mindfulness at baseline, during intervention (5-weeks), post-intervention (9-weeks), and follow-up (12-weeks post-baseline). RESULTS: Participants assigned to AMT reported higher QOL, compared with those assigned to WC, from baseline through follow-up t(258.40) = 3.09, P < 0.01, 95% CI [2.71, 11.90]. Participants assigned to AMT also reported higher dispositional mindfulness, compared with those assigned to WC, from baseline through follow-up t(268.44) = 2.04, P = 0.04, 95% CI [0.01, 0.57]. App utilization data was obtained from 34 participants. Fewer participants assigned to AMT completed all study assessments, compared with participants assigned to WC, (χ2 CONCLUSIONS: Findings suggest commercially available AMT may proffer some benefit to women seeking to enhance their QOL following breast cancer diagnosis.

Medical Subject Headings (MeSH)
AdultAnxietyBreast NeoplasmsFemaleHumansMiddle AgedMindfulnessMobile ApplicationsPatient Education as TopicQuality of LifeStress, PsychologicalWaiting Lists
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations67
Citations/Year9.6
Relative Citation Ratio3.80
NIH Percentile89.4%
Research Impact Scores
APT Score0.95
Weight Score2.32
Normalized Score0.66
Related Supplements
Quality of life among women diagnosed with breast Cancer: A ... | Panacea Index